Inspired by the incredible viewer response to its Emmy Award winning series Intervention, A&E created The Recovery Project to raise awareness that addiction is a treatable disease and recovery is possible. The campaign seeks to break the stigma of addiction and build a bridge between those who are suffering and those who can help. For more information, visit www.therecoveryproject.com or www.facebook.com/therecoveryproject.

The Department of Behavioral Health and Intellectual disAbility Services (DBHIDS) provides comprehensive behavioral health and intellectual disability services through a provider network. DBHIDS is comprised of the Office of Addiction Services (OAS), The Office of Mental Health (OMH), Community Behavioral Health, and Intellectual disAbility Services.

Alkermes, Inc. is a fully integrated biotechnology company that uses proprietary technologies and know-how to create innovative medicines designed to yield better therapeutic outcomes for patients with serious diseases, including central nervous system disorders, addiction and diabetes.

The mission of the Bucks County Drug and Alcohol Commission, Inc., is to promote healthy individuals, families and communities; eliminate the misuse, abuse and/or addiction to alcohol, tobacco and other drugs; and support those in recovery from addiction. BCDAC, Inc., is a component of Bucks County Behavioral Health Services and serves as the Single County Authority (SCA) on alcohol, tobacco and other drug issues, ensuring the provision of a comprehensive and balanced continuum of quality prevention, intervention, treatment and recovery services for the county.

The GCADA leads New Jersey's efforts to plan for and coordinate addiction prevention, treatment and recovery policies and services, as well as to raise public awareness regarding alcoholism and drug abuse. The Council also administers the State's $10 million Municipal Alliance Program, the largest network of community-based anti-drug coalitions in the nation with 7,000 volunteers serving on 395 Alliances encompassing 529 municipalities statewide.

Reckitt Benckiser Pharmaceuticals Inc. is a specialty pharmaceutical company that is committed to expanding access to and the treatment of opioid dependence with proven medical therapies and necessary psychosocial support for patients suffering from this chronic, relapsing brain disease. Reckitt Benckiser Pharmaceuticals Inc. is a wholly-owned subsidiary of Reckitt Benckiser Group plc, a publicly traded UK firm. For more information, visit rb.com or turntohelp.com.

The Council is a nonprofit organization whose mission is to provide resources and opportunities to reduce the impact of addiction and improve related health issues for the communities of southeast Pennsylvania (Bucks, Chester, Delaware, Montgomery and Philadelphia counties). We accomplish this through prevention, consultation, education, advocacy, assessment, intervention and treatment services. We make our services to all, regardless of ability to pay, ethnicity, race, gender, age or sexual/gender orientation.